Evidence map›Paper›PMID 25145852›Full record

ArticleBiomaterials2014

The promotion of functional urinary bladder regeneration using anti-inflammatory nanofibers.

Matthew I Bury, Natalie J Fuller, Jay W Meisner, Matthias D Hofer, Matthew J Webber, Lesley W Chow, Sheba Prasad, Hatim Thaker, Xuan Yue, Vani S Menon and 4 more

Abstract read
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Radiology of fibrosis part III: genitourinary system.Journal of translational medicine · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Delivery strategies to control inflammatory response: Modulating M1-M2 polarization in tissue engineering applications.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Matthew I BuryAnn & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Urology, Chicago, IL 60614, USA.
Natalie J FullerAnn & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Urology, Chicago, IL 60614, USA.
Jay W MeisnerNorthwestern University, Evanston, IL 60208, USA.
Matthias D HoferNorthwestern University Feinberg School of Medicine, Department of Urology, Chicago, IL 60611, USA.
Matthew J WebberNorthwestern University, Institute for BioNanotechnology in Medicine (IBNAM), Chicago, IL 60611, USA; Department of Biomedical Engineering, Evanston, IL 60208, USA.
Lesley W ChowImperial College London, Royal School of Mines, Department of Materials and Institute for Biomedical Engineering, London, UK.
Sheba PrasadAnn & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Urology, Chicago, IL 60614, USA.
Hatim ThakerAnn & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Urology, Chicago, IL 60614, USA.
Xuan YueNorthwestern University, Institute for BioNanotechnology in Medicine (IBNAM), Chicago, IL 60611, USA.
Vani S MenonDepartment of Urology, Loyola University Health System, Maywood, IL 60153, USA.
Edward C DiazAnn & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Urology, Chicago, IL 60614, USA.
Samuel I StuppNorthwestern University, Institute for BioNanotechnology in Medicine (IBNAM), Chicago, IL 60611, USA; Northwestern University, Department of Materials Science and Engineering, Evanston, IL 60208, USA; Northwestern University, Department of Chemical and Biological Engineering, Evanston, IL 60208, USA; Northwestern University Feinberg School of Medicine, Department of Medicine, Chicago, IL 60611, USA.
Earl Y ChengAnn & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Urology, Chicago, IL 60614, USA; Northwestern University Feinberg School of Medicine, Department of Urology, Chicago, IL 60611, USA; Northwestern University, Institute for BioNanotechnology in Medicine (IBNAM), Chicago, IL 60611, USA.
Arun K SharmaAnn & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Urology, Chicago, IL 60614, USA; Northwestern University Feinberg School of Medicine, Department of Urology, Chicago, IL 60611, USA; Northwestern University, Institute for BioNanotechnology in Medicine (IBNAM), Chicago, IL 60611, USA; Department of Biomedical Engineering, Evanston, IL 60208, USA. Electronic address: arun-sharma@northwestern.edu.
Lurie Children's Hospital · USNorthwestern University · USEvanston Hospital · USImperial College London · GBLoyola Medicine · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Regenerative Scaffold Technologies for CNS and DiabetesR01EB003806 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI STUPP, SAMUEL I · 2004 to 2015
$10.7M
Nanotechnology Strategies for Growth of Bones and TeethR01DE015920 · NIDCR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SNEAD, MALCOLM L., STUPP, SAMUEL I · 2005 to 2015
$5.8M
NCI NIH HHS P30 CA060553NIBIB NIH HHS R01 EB003806NIBIB NIH HHS R01EB003806NIDCR NIH HHS R01 DE015920NIDCR NIH HHS R01DE015920
6 · The paper itself

Abstract

Current attempts at tissue regeneration utilizing synthetic and decellularized biologic-based materials have typically been met in part by innate immune responses in the form of a robust inflammatory reaction at the site of implantation or grafting. This can ultimately lead to tissue fibrosis with direct negative impact on tissue growth, development, and function. In order to temper the innate inflammatory response, anti-inflammatory signals were incorporated through display on self-assembling peptide nanofibers to promote tissue healing and subsequent graft compliance throughout the regenerative process. Utilizing an established urinary bladder augmentation model, the highly pro-inflammatory biologic scaffold (decellularized small intestinal submucosa) was treated with anti-inflammatory peptide amphiphiles (AIF-PAs) or control peptide amphiphiles and used for augmentation. Significant regenerative advantages of the AIF-PAs were observed including potent angiogenic responses, limited tissue collagen accumulation, and the modulation of macrophage and neutrophil responses in regenerated bladder tissue. Upon further characterization, a reduction in the levels of M2 macrophages was observed, but not in M1 macrophages in control groups, while treatment groups exhibited decreased levels of M1 macrophages and stabilized levels of M2 macrophages. Pro-inflammatory cytokine production was decreased while anti-inflammatory cytokines were up-regulated in treatment groups. This resulted in far fewer incidences of tissue granuloma and bladder stone formation. Finally, functional urinary bladder testing revealed greater bladder compliance and similar capacities in groups treated with AIF-PAs. Data demonstrate that AIF-PAs can alleviate galvanic innate immune responses and provide a highly conducive regenerative milieu that may be applicable in a variety of clinical settings.

Indexed as

AnimalsAnti-Inflammatory AgentsFemaleImmunity, InnateIntestinal MucosaIntestine, SmallMacrophagesNanofibersNeutrophilsRatsRats, NudeRegenerationTissue ScaffoldsUrinary BladderAnti-Inflammatory AgentsAngiogenesisBladder tissue engineeringInflammationSelf-assemblyUrinary tractWound healing

Identifiers

PMID25145852
PMCPMC4269163
OpenAlexW2115004477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.